Revel Pharmaceuticals
PrivateLast Round
Grant
Aug 15, 2023
Total Funding Raised
$8.95M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Revel Pharmaceuticals is a biotechnology company developing therapeutic enzymes designed to degrade molecular damage associated with aging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revel Pharmaceuticals Comparables
Compare Revel Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lento Bio, Inc. | 74% | |
| Oisín Biotechnologies | 71% | |
| Rejuvenation Technologies | 71% |
Revel Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 15, 2023 | ||||
| Seed | Mar 17, 2022 | ||||
| Seed | Jan 7, 2020 |
Revel Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kizoo Technology Capital | Seed |
| Starbloom Capital | Seed |
| NIH RADx | Grant |
| Tubus LLC | Seed |
| National Institute on Aging | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 270% MoM, reaching 9.8K.
- Mar 1, 2026
Monthly visitors increased 267% MoM.
Revel Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Revel Pharmaceuticals's valuation, stock price, and market status.
Is Revel Pharmaceuticals a public or private company?
Revel Pharmaceuticals is a private company.
What is the current stock price of Revel Pharmaceuticals?
Revel Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Revel Pharmaceuticals worth (valuation)?
Valuation information for Revel Pharmaceuticals is not publicly available.
Can I buy Revel Pharmaceuticals stock?
Revel Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Revel Pharmaceuticals's last funding round?
Revel Pharmaceuticals's most recent funding round was Grant on August 15, 2023.
Who are the main investors in Revel Pharmaceuticals?
Key investors in Revel Pharmaceuticals include Kizoo Technology Capital, Starbloom Capital.
Will Revel Pharmaceuticals IPO soon?
No public IPO plans have been announced for Revel Pharmaceuticals.
How can I track Revel Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Revel Pharmaceuticals's secondary market activity and sign up for updates.